[REFERENCE TRANSLATION]

Please note that this translation is to be used solely as reference and the financial statements in this material are unaudited. In case of any discrepancy between this translation and the Japanese original, the latter shall prevail.

This translation is subject to change without notice. Linical Co., Ltd. shall accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.

Consolidated Financial Results

for the Six Months Ended September 30, 2022

(Japanese GAAP)

November 14, 2022

Company name

Linical Co., Ltd.

Stock Listing

Tokyo Stock Exchange

Code No.

2183

URL

https://www.linical.co.jp/

Representative

Kazuhiro Hatano, President & Chief Executive Officer

Contact

Akihiro Takahashi, Executive Vice President, Chief Financial Officer

Scheduled date of filing of quarterly report

: November 14, 2022

Scheduled date of start of dividend payment

:

Preparation of supplementary materials for the quarterly

: Yes

financial statements

: Yes (for institutional investors and analysts)

Holding of presentation for the quarterly financial results

All amounts are rounded down to the nearest million yen

1Consolidated Financial Results for the Six Months Ended September 30, 2022

April 1, 2022 to September 30, 2022

(1)Consolidated Financial Results (cumulative)

% figures show year-on-year change

Net sales

Operating income

Ordinary income

Profit attributable to

owners of parent

Six Months Ended

(¥ million)

change()

(¥ million)

change()

(¥ million)

change()

(¥ million)

change()

September 30, 2022

5,920

7.2

373

26.4

614

23.9

468

85.6

September 30, 2021

5,522

10.9

507

173.0

496

259.3

252

Note Comprehensive income

Six Months Ended September 30, 2022:

¥943 million (244.9 %)

Six Months Ended September 30, 2021:

¥273 million ( - %)

Net income per share

Diluted net income

per share

Six Months Ended

(¥)

(¥)

September 30, 2022

20.76

September 30, 2021

11.18

(2)Consolidated Financial Position

Total assets

Net assets

Shareholders'

Net asset per

equity ratio

share

(¥ million)

(¥ million)

()

(¥)

As of September 30, 2022

17,265

7,170

41.5

317.46

As of March 31, 2022

15,716

6,543

41.6

289.69

ReferenceShareholder's equity:

As of September

30, 2022:

¥7,170

million

As of March 31, 2022:

¥6,543million

2Dividends

Annual dividends per share (¥)

1st Quarter End

2nd Quarter End

3rdQuarter End

Fiscal

Total

Year End

Year Ended March 31, 2022

0.00

14.00

14.00

Year Ending March 31, 2023

0.00

Year Ending March 31,

14.00

14.00

2023(Forecast)

(NoteChange in the dividend forecast from the most recent announcement: No

3Forecast of Consolidated Financial Result for the Year Ending March 31, 2023

(April 1, 2022 to March 31, 2023)

% figures show year-on-year change

Profit attributable

Net income

Net sales

Operating income

Ordinary income

to owners of

per share

parent

(¥ million)

(¥ million)

(¥ million)

(¥ million)

(¥)

Full year

12,440

7.7

1,224

12.7

1,204

1.7

871

10.2

38.56

(NoteChange in forecasts of consolidated financial results from the most recent announcement: No

Notes

subsidiaries during the

period(changes in specified

(1)Changes in significant

No

subsidiaries that caused changes in scope of consolidation)

New:

-

(Company Name)

-

Exclusion:

-

(Company Name)

-

(2)Adoption of accounting methods specific to the preparation of quarterly consolidated financial statements

(3)Changes in accounting policies, accounting estimates and restatements

1)Changes in accounting policies resulting from the revision of the accounting standards and other regulations

2)Changes in accounting policies other than 1) 3)Changes in accounting estimates 4)Restatements

(4)Number of issued shares (Common share)

(a)Number of issued shares at the end of the period (including treasury shares)

No

Yes

No

No

No

As of

September 30, 2022

As of

March 31, 2022

(b) Number of treasury shares at the end of the period

As of

September 30, 2022

As of

March 31, 2022

  1. Average number of shares during the period Six Months Ended September 30, 2022 Six Months Ended September 30, 2021

24,740,000 shares

24,740,000 shares

2,153,564 shares

2,153,564 shares

22,586,436 shares

22,586,436 shares

  • This release is outside the scope of the external auditor's quarterly review procedure.
  • Explanation on appropriate use of forecast and other special items

This material contains business forecast and other forward-looking statements which are based on available information and certain assumptions that are considered reasonable at the time of preparation. Various factors may cause actual results to be materially different from those expressed in these forward- looking statements.

*How to obtain supplementary results briefing material on quarterly financial results

The Company plans to hold a quarterly financial results presentation meeting on November 25, 2022. The Company also plans to post to its website the materials that are used at the meeting immediately after the event.

Consolidated Balance Sheets

(Thousands of yen)

As of March 31, 2022

As of September 30, 2022

Assets

Current assets

Cash and deposits

5,985,618

6,303,008

Accounts receivable - trade and contrac

2,917,990

3,113,677

Prepaid expenses

197,784

284,425

Advances paid

987,891

1,438,365

Other

266,645

359,309

Allowance for doubtful accounts

34,842

13,181

Total current assets

10,321,087

11,485,605

Non-current assets

Property, plant and equipment

664,111

664,019

Intangible assets

Goodwill

3,406,633

3,765,610

Other

159,249

150,876

Total intangible assets

3,565,883

3,916,487

Investments and other assets

Investment securities

347,652

328,045

Long-term prepaid expenses

5,461

2,146

Guarantee deposits

366,280

375,171

Deferred tax assets

445,992

494,374

Total investments and other assets

1,165,387

1,199,737

Total non-current assets

5,395,381

5,780,243

Total assets

15,716,469

17,265,848

Consolidated Balance Sheets

(Thousands of yen)

As of March 31, 2022

As of September 30, 2022

Liabilities

Current liabilities

Short-term borrowings

600,000

600,000

Current portion of long-term borrowings

539,976

539,976

Accounts payable - other

533,842

812,141

Accrued expenses

402,485

321,055

Income taxes payable

193,650

265,210

Accrued consumption taxes

38,747

94,539

Advances received

2,147,272

2,411,239

Deposits received

688,038

1,305,346

Provision for bonuses

171,809

166,418

Other

162,279

140,984

Total current liabilities

5,478,102

6,656,911

Non-current liabilities

Long-term borrowings

2,533,566

2,263,578

Lease liabilities

430,959

431,181

Retirement benefit liability

689,644

712,145

Other

41,028

31,803

Total non-current liabilities

3,695,198

3,438,707

Total liabilities

9,173,300

10,095,618

Net assets

Shareholders' equity

Share capital

214,043

214,043

Retained earnings

6,604,985

6,757,589

Treasury shares

657,461

657,461

Total shareholders' equity

6,161,567

6,314,170

Accumulated other comprehensive income

Valuation difference on available-for-

42,339

32,821

sale securities

Foreign currency translation adjustment

322,124

806,757

Remeasurements of defined benefit plans

17,138

16,480

Total accumulated other comprehensive

381,601

856,058

income

Total net assets

6,543,169

7,170,229

Total liabilities and net assets

15,716,469

17,265,848

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Linical Co. Ltd. published this content on 14 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2022 07:31:05 UTC.